share_log

Needham:重申Taysha Gene Therapies(TSHA.US)评级,由买入调整至买入评级, 目标价7.00美元。

Needham: Reiterates Taysha Gene Therapies (TSHA.US) rating and adjusted from buy to buy rating, target price is $7.00.

Zhitong Finance ·  Apr 11 18:31
Needham: Reiterates Taysha Gene Therapies (TSHA.US) rating and adjusted from buy to buy rating, target price is $7.00.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment